Literature DB >> 8733951

Three new residual error models for population PK/PD analyses.

M O Karlsson1, S L Beal, L B Sheiner.   

Abstract

Residual error models, traditionally used in population pharmacokinetic analyses, have been developed as if all sources of error have properties similar to those of assay error. Since assay error often is only a minor part of the difference between predicted and observed concentrations, other sources, with potentially other properties, should be considered. We have simulated three complex error structures. The first model acknowledges two separate sources of residual error, replication error plus pure residual (assay) error. Simulation results for this case suggest that ignoring these separate sources of error does not adversely affect parameter estimates. The second model allows serially correlated errors, as may occur with structural model misspecification. Ignoring this error structure leads to biased random-effect parameter estimates. A simple autocorrelation model, where the correlation between two errors is assumed to decrease exponentially with the time between them, provides more accurate estimates of the variability parameters in this case. The third model allows time-dependent error magnitude. This may be caused, for example, by inaccurate sample timing. A time-constant error model fit to time-varying error data can lead to bias in all population parameter estimates. A simple two-step time-dependent error model is sufficient to improve parameter estimates, even when the true time dependence is more complex. Using a real data set, we also illustrate the use of the different error models to facilitate the model building process, to provide information about error sources, and to provide more accurate parameter estimates.

Entities:  

Mesh:

Year:  1995        PMID: 8733951     DOI: 10.1007/bf02353466

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  3 in total

1.  Building population pharmacokinetic--pharmacodynamic models. I. Models for covariate effects.

Authors:  J W Mandema; D Verotta; L B Sheiner
Journal:  J Pharmacokinet Biopharm       Date:  1992-10

2.  Some general estimation methods for nonlinear mixed-effects models.

Authors:  M Davidian; D M Giltinan
Journal:  J Biopharm Stat       Date:  1993-03       Impact factor: 1.051

3.  The importance of modeling interoccasion variability in population pharmacokinetic analyses.

Authors:  M O Karlsson; L B Sheiner
Journal:  J Pharmacokinet Biopharm       Date:  1993-12
  3 in total
  54 in total

1.  Assessment of actual significance levels for covariate effects in NONMEM.

Authors:  U Wählby; E N Jonsson; M O Karlsson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2001-06       Impact factor: 2.745

2.  Serial correlation in optimal design for nonlinear mixed effects models.

Authors:  Joakim Nyberg; Richard Höglund; Martin Bergstrand; Mats O Karlsson; Andrew C Hooker
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-03-14       Impact factor: 2.745

3.  Longitudinal aggregate data model-based meta-analysis with NONMEM: approaches to handling within treatment arm correlation.

Authors:  Jae Eun Ahn; Jonathan L French
Journal:  J Pharmacokinet Pharmacodyn       Date:  2010-04-01       Impact factor: 2.745

Review 4.  Covariate pharmacokinetic model building in oncology and its potential clinical relevance.

Authors:  Markus Joerger
Journal:  AAPS J       Date:  2012-01-25       Impact factor: 4.009

5.  Using stochastic differential equations for PK/PD model development.

Authors:  Niels Rode Kristensen; Henrik Madsen; Steen Hvass Ingwersen
Journal:  J Pharmacokinet Pharmacodyn       Date:  2005-02       Impact factor: 2.745

6.  Non-linear mixed-effects models with stochastic differential equations: implementation of an estimation algorithm.

Authors:  Rune V Overgaard; Niclas Jonsson; Christoffer W Tornøe; Henrik Madsen
Journal:  J Pharmacokinet Pharmacodyn       Date:  2005-02       Impact factor: 2.745

7.  Population pharmacokinetics of onercept in healthy subjects.

Authors:  Sophie Glatt; Eliane Fuseau; Mauro Buraglio; Quyen T X Nguyen
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

8.  Semimechanistic pharmacokinetic/pharmacodynamic model for assessment of activity of antibacterial agents from time-kill curve experiments.

Authors:  Elisabet I Nielsen; Anders Viberg; Elisabeth Löwdin; Otto Cars; Mats O Karlsson; Marie Sandström
Journal:  Antimicrob Agents Chemother       Date:  2006-10-23       Impact factor: 5.191

9.  Stochastic differential equations in NONMEM: implementation, application, and comparison with ordinary differential equations.

Authors:  Christoffer W Tornøe; Rune V Overgaard; Henrik Agersø; Henrik A Nielsen; Henrik Madsen; E Niclas Jonsson
Journal:  Pharm Res       Date:  2005-08-03       Impact factor: 4.200

10.  Predictive performance for population models using stochastic differential equations applied on data from an oral glucose tolerance test.

Authors:  Jonas B Møller; Rune V Overgaard; Henrik Madsen; Torben Hansen; Oluf Pedersen; Steen H Ingwersen
Journal:  J Pharmacokinet Pharmacodyn       Date:  2009-12-16       Impact factor: 2.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.